British drugmaker GSK said on Monday it had submitted an application to the U.S. Food and Drug Administration to extend the ...

A CDC advisory panel vote to recommend against use of seasonal influenza vaccines containing small amounts of thimerosal ...

Advisers to the Centers for Disease Control and Prevention recommended against flu shots containing the ingredient thimerosal ...

Moderna this week announced positive data from a phase 3 trial of its messenger RNA vaccine against seasonal influenza, which ...

This could be America’s future if Robert F. Kennedy Jr. continues his rampage against public health—and it may arrive much ...

The meeting included a discussion of thimerosal, a mercury-based preservative and longtime target of the anti-vaccine world.

The full approval of Spikevax covers children aged six months through 11 years who are at increased risk for severe COVID-19, transitioning the vaccine from emergency use to full licensure.

Kennedy selected a new team of medical professionals and scientists who are highly qualified and dedicated to public health.

The long and winding journey of Moderna’s mRNA flu vaccine toward regulators has come one step closer with a phase 3 win over an approved competitor.

Health experts were shocked to see that thimerosal, a preservative that has largely been phased out of U.S. vaccines, was on ...

The preservative is in a small share of flu shots and has been studied for decades. Experts say it’s safe — despite Kennedy’s long opposition.

Moderna said on Monday its influenza vaccine was found to be 26.6% more effective than an approved annual flu shot from GSK in adults aged 50 years and older in a late-stage study, sending its ...